{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:42:57Z","timestamp":1784180577313,"version":"3.55.0"},"reference-count":57,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>The intestinal microbiota represents the microbial community that colonizes the gastrointestinal tract and constitutes the most complex ecosystem present in nature. The main intestinal microbial phyla are Firmicutes, Bacteroidetes, Actinobacteria, Proteobacteria, Fusobacteria, and Verrucromicrobia, with a clear predominance of the two phyla Firmicutes and Bacteroidetes which account for about 90% of the intestinal phyla. Intestinal microbiota alteration, or dysbiosis, has been proven to be involved in the development of various syndromes, such as non-alcoholic fatty liver disease, Crohn\u2019s disease, and ulcerative colitis. The present review underlines the most recurrent changes in the intestinal microbiota of patients with NAFLD, Crohn\u2019s disease, and ulcerative colitis.<\/jats:p>","DOI":"10.3390\/nu14245323","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T03:01:51Z","timestamp":1671073311000},"page":"5323","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5922-1524","authenticated-orcid":false,"given":"Ludovico","family":"Abenavoli","sequence":"first","affiliation":[{"name":"Department of Health Sciences, University \u201cMagna Graecia\u201d, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Giubilei","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University \u201cMagna Graecia\u201d, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Caterina","family":"Procopio","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University \u201cMagna Graecia\u201d, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0871-4644","authenticated-orcid":false,"given":"Rocco","family":"Spagnuolo","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University \u201cMagna Graecia\u201d, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5120-1046","authenticated-orcid":false,"given":"Francesco","family":"Luzza","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University \u201cMagna Graecia\u201d, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2017-4270","authenticated-orcid":false,"given":"Luigi","family":"Boccuto","sequence":"additional","affiliation":[{"name":"School of Nursing, Clemson University, Clemson, SC 29634, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2101-1118","authenticated-orcid":false,"given":"Emidio","family":"Scarpellini","sequence":"additional","affiliation":[{"name":"Translational Research in Gastrointestinal Disorders (T.A.R.G.I.D.), Gasthuisberg University Hospital, KU Leuven, Herestraat 49, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Abenavoli, L., Scarpellini, E., Colica, C., Boccuto, L., Salehi, B., Sharifi-Rad, J., Aiello, V., Romano, B., De Lorenzo, A., and Izzo, A.A. (2019). Gut Microbiota and Obesity: A Role for Probiotics. Nutrients, 11.","DOI":"10.3390\/nu11112690"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Rinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G.A.D., Gasbarrini, A., and Mele, M.C. (2019). What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms, 7.","DOI":"10.3390\/microorganisms7010014"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1042\/BCJ20160510","article-title":"Introduction to the human gut microbiota","volume":"474","author":"Thursby","year":"2017","journal-title":"Biochem. J."},{"key":"ref_4","first-page":"26050","article-title":"The composition of the gut microbiota throughout life, with an emphasis on early life","volume":"26","author":"Murphy","year":"2015","journal-title":"Microb. Ecol. Health Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12979-020-00213-w","article-title":"Gut microbiota as the key controllers of \u201chealthy\u201d aging of elderly people","volume":"18","author":"Ragonnaud","year":"2021","journal-title":"Immun. Ageing"},{"key":"ref_6","first-page":"339","article-title":"Gut microbiota and non-alcoholic fatty liver disease","volume":"67","author":"Abenavoli","year":"2021","journal-title":"Minerva Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Abenavoli, L., Procopio, A.C., Paravati, M.R., Costa, G., Mili\u0107, N., Alcaro, S., and Luzza, F. (2022). Mediterranean Diet: The Beneficial Effects of Lycopene in Non-Alcoholic Fatty Liver Disease. J. Clin. Med., 11.","DOI":"10.3390\/jcm11123477"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.23736\/S1121-421X.20.02666-5","article-title":"Non-alcoholic fatty liver disease and primary care physicians","volume":"66","author":"Abenavoli","year":"2020","journal-title":"Minerva Gastroenterol. Dietol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Abenavoli, L., Larussa, T., Corea, A., Procopio, A.C., Boccuto, L., Dallio, M., Federico, A., and Luzza, F. (2021). Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease. Nutrients, 13.","DOI":"10.3390\/nu13020494"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(07)60750-8","article-title":"Inflammatory bowel disease: Cause and immunobiology","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1053\/j.gastro.2011.01.055","article-title":"Epidemiology and natural history of inflammatory bowel diseases","volume":"140","author":"Cosnes","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.25122\/jml-2018-0075","article-title":"A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease","volume":"12","author":"Seyedian","year":"2019","journal-title":"J. Med. Life"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Larussa, T., Imeneo, M., and Luzza, F. (2019). Olive Tree Biophenols in Inflammatory Bowel Disease: When Bitter is Better. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061390"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"32002","DOI":"10.1038\/srep32002","article-title":"Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-alcoholic Fatty Liver Disease","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Tsai, M.C., Liu, Y.Y., Lin, C.C., Wang, C.C., Wu, Y.J., Yong, C.C., Chen, K.D., Chuah, S.K., Yao, C.C., and Huang, P.Y. (2020). Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan. Nutrients, 12.","DOI":"10.3390\/nu12030820"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"8096","DOI":"10.1038\/srep08096","article-title":"Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease","volume":"5","author":"Jiang","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s12072-019-09987-8","article-title":"Significant decrease in Faecalibacterium among gut microbiota in nonalcoholic fatty liver disease: A large BMI- and sex-matched population study","volume":"13","author":"Iino","year":"2019","journal-title":"Hepatol. Int."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/jgh.12073","article-title":"Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn\u2019s disease","volume":"28","author":"Fujimoto","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000441768","article-title":"Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn\u2019s Disease","volume":"93","author":"Takahashi","year":"2016","journal-title":"Digestion"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.3748\/wjg.v24.i13.1464","article-title":"Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease","volume":"24","author":"Ma","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00535-010-0368-4","article-title":"Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn\u2019s disease using terminal restriction fragment length polymorphism analysis","volume":"46","author":"Andoh","year":"2011","journal-title":"J. Gastroenterol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/19490976.2016.1190073","article-title":"Composition and function of the pediatric colonic mucosal microbiome in untreated patients with ulcerative colitis","volume":"7","author":"Shah","year":"2016","journal-title":"Gut Microbes"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/ibd\/izaa189","article-title":"Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis","volume":"27","author":"Lin","year":"2021","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"7367","DOI":"10.3748\/wjg.v26.i46.7367","article-title":"Prevalence and risk factors of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: A cross-sectional and longitudinal analysis","volume":"26","author":"Hoffmann","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/ibd\/izy051","article-title":"Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors","volume":"24","author":"Principi","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/MIB.0000000000000569","article-title":"PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes","volume":"22","author":"Mancina","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e13357","DOI":"10.1111\/asj.13357","article-title":"Regulation of the intestinal barrier by nutrients: The role of tight junctions","volume":"91","author":"Suzuki","year":"2020","journal-title":"Anim. Sci. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/gut.2006.094375","article-title":"Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn\u2019s disease","volume":"56","author":"Zeissig","year":"2007","journal-title":"Gut"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0002-9440(10)63051-9","article-title":"Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins","volume":"159","author":"Kucharzik","year":"2001","journal-title":"Am. J. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Santana, P.T., Rosas, S.L.B., Ribeiro, B.E., Marinho, Y., and de Souza, H.S.P. (2022). Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23073464"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Hyun, C.K. (2021). Molecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22179139"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2009.03.008","article-title":"Kupffer cells in non-alcoholic fatty liver disease: The emerging view","volume":"51","author":"Baffy","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrgastro.2010.172","article-title":"The role of the gut microbiota in nonalcoholic fatty liver disease","volume":"7","author":"Quigley","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00894-018-3886-2","article-title":"Roles of the inflammasome in the gut-liver axis (Review)","volume":"19","author":"Wang","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"111442","DOI":"10.1016\/j.biopha.2021.111442","article-title":"Targeting the NLRP3 inflammasome as new therapeutic avenue for inflammatory bowel disease","volume":"138","author":"Chen","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Perri, A., Bossio, S., Rago, V., Greco, E.A., Lofaro, D., LA Russa, A., DI Luigi, L., LA Vignera, S., and Aversa, A. (2022). NLRP3-inflammasome activation in male reproductive system diseases. Minerva Endocrinol.","DOI":"10.23736\/S2724-6507.22.03918-5"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","article-title":"Inflammasome activation and regulation: Toward a better understanding of complex mechanisms","volume":"6","author":"Zheng","year":"2020","journal-title":"Cell Discov."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12943-018-0900-3","article-title":"Role of the NLRP3 inflammasome in cancer","volume":"17","author":"Moossavi","year":"2018","journal-title":"Mol. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.molimm.2018.10.015","article-title":"Palmatine attenuated dextran sulfate sodium (DSS)-induced colitis via promoting mitophagy-mediated NLRP3 inflammasome inactivation","volume":"105","author":"Mai","year":"2019","journal-title":"Mol. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"6489012","DOI":"10.1155\/2016\/6489012","article-title":"Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH","volume":"2016","author":"Wan","year":"2016","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"He, J., Zhang, P., Shen, L., Niu, L., Tan, Y., Chen, L., Zhao, Y., Bai, L., Hao, X., and Li, X. (2020). Short-Chain Fatty Acids and Their Association with Signalling Pathways in Inflammation, Glucose and Lipid Metabolism. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176356"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3390\/livers2030012","article-title":"Therapeutic Potential of Human Microbiome-Based Short-Chain Fatty Acids and Bile Acids in Liver Disease","volume":"2","author":"Ganesan","year":"2022","journal-title":"Livers"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1007\/s00394-020-02431-w","article-title":"A bridge for short-chain fatty acids to affect inflammatory bowel disease, type 1 diabetes, and non-alcoholic fatty liver disease positively: By changing gut barrier","volume":"60","author":"Liu","year":"2021","journal-title":"Eur. J. Nutr."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Chen, J., and Vitetta, L. (2020). Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155214"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3389\/fmed.2020.00361","article-title":"Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD","volume":"7","author":"Jiang","year":"2020","journal-title":"Front. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ebiom.2018.03.030","article-title":"Sodium Butyrate Inhibits Inflammation and Main-tains Epithelium Barrier Integrity in a TNBS-induced Inflammatory Bowel Disease Mice Model","volume":"30","author":"Chen","year":"2018","journal-title":"EBioMedicine"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Zhang, M., Zhou, Q., Dorfman, R.G., Huang, X., Fan, T., Zhang, H., Zhang, J., and Yu, C. (2016). Butyrate inhibits interleukin-17 and generates Tregs to ameliorate colorectal colitis in rats. BMC Gastroenterol., 16.","DOI":"10.1186\/s12876-016-0500-x"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"700058","DOI":"10.3389\/fnut.2021.700058","article-title":"Role of the Gut Microbiota in Regulating Non-alcoholic Fatty Liver Disease in Children and Adolescents","volume":"8","author":"Tokuhara","year":"2021","journal-title":"Front. Nutr."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Vallianou, N., Christodoulatos, G.S., Karampela, I., Tsilingiris, D., Magkos, F., Stratigou, T., Kounatidis, D., and Dalamaga, M. (2021). Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives. Biomolecules, 12.","DOI":"10.3390\/biom12010056"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s12072-010-9202-6","article-title":"Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease","volume":"4","author":"Yang","year":"2010","journal-title":"Hepatol. Int."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD","volume":"67","author":"Jiao","year":"2018","journal-title":"Gut"},{"key":"ref_52","first-page":"11","article-title":"Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease","volume":"7","author":"Zhou","year":"2021","journal-title":"Hepatoma Res."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Appleby, R.N., Moghul, I., Khan, S., Yee, M., Manousou, P., Neal, T.D., and Walters, J.R.F. (2019). Non-alcoholic fatty liver disease is associated with dysregulated bile acid synthesis and diarrhea: A prospective observational study. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0211348"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Yang, M., Gu, Y., Li, L., Liu, T., Song, X., Sun, Y., Cao, X., Wang, B., Jiang, K., and Cao, H. (2021). Bile Acid-Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside. Nutrients, 13.","DOI":"10.3390\/nu13093143"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/ceh.2019.83151","article-title":"Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease","volume":"5","author":"Augustyn","year":"2019","journal-title":"Clin. Exp. Hepatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"756299","DOI":"10.3389\/fmicb.2021.756299","article-title":"Dextran Sulfate Sodium Salt-Induced Colitis Aggravates Gut Microbiota Dysbiosis and Liver Injury in Mice with Non-alcoholic Steatohepatitis","volume":"12","author":"Shen","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Gibiino, G., Binda, C., Cristofaro, L., Sbrancia, M., Coluccio, C., Petraroli, C., Jung, C.F.M., Cucchetti, A., Cavaliere, D., and Ercolani, G. (2022). Dysbiosis and Gastrointestinal Surgery: Current Insights and Future Research. Biomedicines, 10.","DOI":"10.3390\/biomedicines10102532"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/14\/24\/5323\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:41:37Z","timestamp":1760146897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/14\/24\/5323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":57,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["nu14245323"],"URL":"https:\/\/doi.org\/10.3390\/nu14245323","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]}}}